Could cause temporary or reversible harm; serious harm is unlikely.
Failed Dissolution Specifications
| Brand name | POTASSIUM CHLORIDE |
| Generic name | POTASSIUM CHLORIDE |
| Active ingredient(s) | POTASSIUM CHLORIDE |
| Distributed by / for | Strides Pharma Inc., East Brunswick NJ 08816 |
| NDC | 64380-860-06 |
| Full product label | Strides Pharma Inc.Potassium Chloride Extended-Release Tablets, USP 8mEq (600 mg) 100 Tablets Rx Only Manufactured by: Strides Pharma Science Limited Bengaluru -562106 India Distributed by: Strides Pharma Inc., East Brunswick NJ 08816 NDC 64380-860-06 |
| Recalling firm | Strides Inc. |
| Distribution | nationwide |
| Quantity | 11,280 bottles |
| Recall initiated | 2020-08-24 |
| Report date | 2020-10-07 |
| Recall completed | 2022-01-11 |
| Recall number | D-0001-2021 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Lambertville NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗